For the Inventor, By the Inventor

Enter assignee name

Rhone-Poulenc Sante

Calculating rank

USPTO Granted Patents = 192

Forward Citations = 1,640

Loading Chart...

Loading Chart...

186 inventors (with patents filed for the assignee):

Daniel Farge (29 out of 89 patents)

Claude Cotrel (18 out of 45 patents)

Claude James (18 out of 27 patents)

4. Christian L Renault (13 out of 22 patents)

5. Gerard Roussel (12 out of 18 patents)

6. Didier Morel (12 out of 19 patents)

7. Jean-Marc Paris (11 out of 21 patents)

8. Michel Mulhauser (11 out of 15 patents)

9. Jean-Francois Peyronel (10 out of 30 patents)

10. Jean-Luc Malleron (9 out of 32 patents)

11. Claude Guyon (9 out of 24 patents)

12. Daniel Lave (9 out of 9 patents)

13. Marie-Christine Dubroeucq (9 out of 27 patents)

14. Gerard Mignani (8 out of 41 patents)

15. Claude Gueremy (8 out of 14 patents)

Core Competencies:

Enantioselective Amidases

Thioformamide Derivatives

Pharmaceutical Compositions

Terpene Derivatives

Isoindolone Derivatives

Pyrrole Derivatives

Analgesic Compounds

Sustained Release Formulations

Catalysts

Active Constituents

Serotonin Antagonists

Animal Nutrition

192 patents: Sort by Forward Citations

1. 5766918 - Enantioselective amidases and uses thereof (1998-06-16),

2. 5426117 - N-methyl-2-(3-pyridyl)-tetrahydrothio-pyran-2-carbothioamide 1-oxide to (1995-06-20),

3. 5304642 - Pristinaymcinia or virginiamycin derivatives and their preparation (1994-04-19),

4. 5298248 - Method for continuous liberation of active constituents into water (1994-03-29),

5. 5276045 - Thioformamide derivative, process for its preparation, pharmaceutical (1994-01-04),

6. 5274178 - Terpene derivatives, their preparation and their use (1993-12-28),

7. 5260208 - Enantioselective amidases, DNA sequences encoding them, method of (1993-11-09),

8. 5246950 - Thioformamide derivatives (1993-09-21),

9. 5244881 - Compositions based on imipyramine (1993-09-14),

10. 5236940 - Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their (1993-08-17),

11. 5223529 - N-phenylamides and medicinal products containing them (1993-06-29),

12. 5206025 - Porous pharmaceutical form and its preparation (1993-04-27),

13. 5202460 - Terpene derivatives, their preparation and their use (1993-04-13),

14. 5188841 - Sustained release pharmaceutical formulations (1993-02-23),

15. 5188838 - Process for the preparation of medications in the form of pearls (1993-02-23),

Company Overview

Rhone-Poulenc Sante, headquartered in Antony, France, is a prominent player in the pharmaceutical industry, specializing in the development and manufacturing of innovative pharmaceutical compositions. The company focuses on advanced technologies such as enantioselective amidases and various derivatives, including thioformamide, terpene, isoindolone, and pyrrole derivatives. Their expertise extends to formulating analgesic compounds and sustained release formulations, positioning them at the forefront of pharmaceutical research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

192 Patents

#3 in Antony

#149 in France

#4,381 in the World

Rhone-Poulenc Sante

Forward Citations = 1,640

186 inventors:

Daniel Farge (29 out of 89 patents)

Claude Cotrel (18 out of 45 patents)

Claude James (18 out of 27 patents)

4. Christian L Renault (13 out of 22 patents)

5. Gerard Roussel (12 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rhone-Poulenc Sante. Retrieved from https://idiyas.com/company/rhone-poulenc-sante

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…